Biotech | March 23, 2022
Arum Therapeutics implements CDD Vault to streamline research data
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
First PARP inhibitor to demonstrate overall survival benefit in early breast cancer
According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years
The investment will accelerate the overall Sarclisa development program
He has over 25 years of rich experience in marketing and business in various sectors
Subscribe To Our Newsletter & Stay Updated
